About Synexus Magyarorszag Kft.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Eli Lilly and Company
2
Janssen Research & Development, LLC
2
Phathom Pharmaceuticals, Inc.
2
Allergan
1
Fidia Farmaceutici s.p.a.
1
Gilead Sciences
1
Incyte Corporation
1
Intercept Pharmaceuticals
1
Regeneron Pharmaceuticals
1
Clinical Trials at Synexus Magyarorszag Kft.
During the past decade, Synexus Magyarorszag Kft. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on
average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
2017-08-17
2021-08-27
Completed
3,307
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
2018-02-16
2020-07-16
Terminated
311
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
2017-08-30
2022-09-08
Completed
919
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2018-10-29
2020-03-06
Completed
838
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Synexus Magyarorszag Kft." #1 sponsor was "Pfizer" with 4 trials, followed by "Eli Lilly and Company" with 2 trials
sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Phathom Pharmaceuticals, Inc." with 2 trials sponsored and "Allergan"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Magyarorszag Kft."
#1 collaborator was "Galapagos NV" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Synexus Magyarorszag Kft.
According to Clinical.Site data, the most researched conditions in "Synexus Magyarorszag Kft." are
"Crohn's Disease" (3 trials), "Cardiovascular Disease" (2 trials), "Dermatitis, Atopic" (2 trials), "Atopic Dermatitis" (1 trials) and "Compensated Cirrhosis" (1 trials). Many other conditions were trialed in "Synexus Magyarorszag Kft." in a lesser frequency.
Clinical Trials Intervention Types at Synexus Magyarorszag Kft.
Most popular intervention types in "Synexus Magyarorszag Kft." are "Drug" (16 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Guselkumab" (2 trials), "Lansoprazole" (2 trials), "Mirikizumab" (2 trials) and "Ustekinumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Synexus Magyarorszag Kft.
The vast majority of trials in "Synexus Magyarorszag Kft." are
16 trials for "All" genders.
Clinical Trials Status at Synexus Magyarorszag Kft.
Currently, there are NaN active trials in "Synexus Magyarorszag Kft.".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Synexus Magyarorszag Kft.,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Magyarorszag Kft., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".